MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
Recruiting · NCT07463651 · Registry updated 2026-03-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 3 | 2026-03-20 | NCT07463651 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital of Soochow University | 164 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ruijin Hospital, Shanghai Jiaotong University School of Medicine | Shanghai | China | 45 |
| the First Affiliated Hosptital of Soochow University | Suzhou | China | 1 |